Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775590 · ClinicalTrials.gov registry record · NA
The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03775590: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03775590 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03775590, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
To evaluate the efficacy of water bath, water + bleach, and water + vinegar (acetic acid) in the treatment of atopic dermatitis (eczema)
Primary Outcome
The EASI score is a validated composite score that ranges from 0 (clear) to 72 (very severe). The EASI is assessed and calculated as: the proportion of affected body surface area (BSA) was estimated from 4 designated body regions (head/neck, upper limbs, trunk, and lower limbs), and the Physician's Assessment of Individual Signs was determined for each region. The Physician's Assessment of Individual Signs grades signs of AD (erythema, edema/induration/papulation, excoriation, oozing/weeping/cru
Interventions
- PROCEDURE Water
- PROCEDURE Bleach
- PROCEDURE Acetic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-02-21 |
| Est. Completion | 2019-09-15 |
| Phase | NA |
Why NCT03775590 stopped before completion
NCT03775590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 3 interventions - of which Water is the first listed.
NCT03775590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03775590 about?
NCT03775590 is a clinical study titled "The Role of Bathing Additives in the Treatment of Pediatric Atopic Dermatitis". To evaluate the efficacy of water bath, water + bleach, and water + vinegar (acetic acid) in the treatment of atopic dermatitis (eczema)
What is the current status of trial NCT03775590?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-02-21. Estimated completion is 2019-09-15.
What interventions are being tested in trial NCT03775590?
The interventions under investigation include: Water (PROCEDURE), Bleach (PROCEDURE), Acetic acid (PROCEDURE).
Who is sponsoring clinical trial NCT03775590?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03775590's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI